Pfizer-BioNTech Bivalent COVID-19 Booster Produces Higher Response In Older Adults Against Subvariant BQ.1.1 Than Original Vaccine, Data Suggest

Reuters (11/18, Satija, Mishra, Leo) reported Pfizer and partner BioNTech “said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.” Reuters...